- Home
- JYD vs LGVN Comparison
JYD vs LGVN Comparison
Compare JYD & LGVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JYD
- LGVN
- Stock Information
- Founded
- JYD 2001
- LGVN 2014
- Country
- JYD China
- LGVN United States
- Employees
- JYD N/A
- LGVN N/A
- Industry
- JYD Oil Refining/Marketing
- LGVN Medicinal Chemicals and Botanical Products
- Sector
- JYD Consumer Discretionary
- LGVN Health Care
- Exchange
- JYD Nasdaq
- LGVN Nasdaq
- Market Cap
- JYD 18.9M
- LGVN 16.4M
- IPO Year
- JYD 2023
- LGVN 2021
- Fundamental
- Price
- JYD $0.14
- LGVN $0.75
- Analyst Decision
- JYD
- LGVN Strong Buy
- Analyst Count
- JYD 0
- LGVN 2
- Target Price
- JYD N/A
- LGVN $6.50
- AVG Volume (30 Days)
- JYD 940.9K
- LGVN 416.4K
- Earning Date
- JYD 10-24-2025
- LGVN 11-11-2025
- Dividend Yield
- JYD N/A
- LGVN N/A
- EPS Growth
- JYD N/A
- LGVN N/A
- EPS
- JYD N/A
- LGVN N/A
- Revenue
- JYD $77,444,271.00
- LGVN $2,073,000.00
- Revenue This Year
- JYD N/A
- LGVN N/A
- Revenue Next Year
- JYD N/A
- LGVN N/A
- P/E Ratio
- JYD N/A
- LGVN N/A
- Revenue Growth
- JYD 13.54
- LGVN 68.67
- 52 Week Low
- JYD $0.09
- LGVN $0.63
- 52 Week High
- JYD $8.00
- LGVN $2.48
- Technical
- Relative Strength Index (RSI)
- JYD 36.82
- LGVN 35.53
- Support Level
- JYD $0.13
- LGVN $0.74
- Resistance Level
- JYD $0.16
- LGVN $0.85
- Average True Range (ATR)
- JYD 0.01
- LGVN 0.05
- MACD
- JYD -0.00
- LGVN 0.02
- Stochastic Oscillator
- JYD 34.21
- LGVN 21.23
About JYD Jayud Global Logistics Limited
Jayud Global Logistics Ltd is an end-to-end supply chain solution provider in China, with a focus on providing cross-border logistics services. The company offers freight forwarding services, supply chain management, and other value-added services.
About LGVN Longeveron Inc.
Longeveron Inc is a clinical-stage biotechnology company developing regenerative medicines to address unmet medical needs for specific aging-related and life-threatening conditions. Its investigational product is Lomecel-B an stem cell formulation sourced from the bone marrow of young, healthy adult donors and has potential mechanisms of action that can promote tissue repair and healing. The company currently has three pipeline indications: Hypoplastic Left Heart Syndrome (HLHS), Alzheimer's disease (AD) and Aging-related Frailty.